Inventor · disambiguated record
David Neil Hayes
Also filed as: HAYES DAVID N · HAYES DAVID NEIL
9 granted patents·11 pending applications·63 citations·filing 2008–2023
83Inventor score
Files withGENECENTRIC THERAPEUTICS INC14UNIV NORTH CAROLINA4HAYES DAVID N1UNIV NORTH CAROLINA CHAPEL HILL1
Top patents by PatentIndex Score
20 records- 0193US8822153B2Molecular diagnosis and typing of lung cancer variantsHAYES DAVID N·Filed 2008·Granted Sep 2, 2014·51 cites·5 claims
- 0286US10934595B2Methods for subtyping of lung adenocarcinomaGENECENTRIC THERAPEUTICS INC·Filed 2017·Granted Mar 2, 2021·4 cites·11 claims
- 0385US11739386B2Methods for determining response to PARP inhibitorsGENECENTRIC THERAPEUTICS INC·Filed 2018·Granted Aug 29, 2023·3 cites·9 claims
- 0482US11041214B2Methods for subtyping of lung squamous cell carcinomaGENECENTRIC THERAPEUTICS INC·Filed 2017·Granted Jun 22, 2021·2 cites·14 claims
- 0581US10829819B2Methods for typing of lung cancerGENECENTRIC THERAPEUTICS INC·Filed 2015·Granted Nov 10, 2020·3 cites·15 claims
- 0674US2022243283A1Methods for typing of lung cancerGENECENTRIC THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0771US2022002820A1Methods for typing of lung cancerGENECENTRIC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0870US2023395263A1Gene expression subtype analysis of head and neck squamous cell carcinoma for treatment managementGENECENTRIC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0968US2021147948A1Methods for typing of lung cancerGENECENTRIC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1066US12139765B2Methods for subtyping of lung squamous cell carcinomaGENECENTRIC THERAPEUTICS INC·Filed 2021·Granted Nov 12, 2024·0 cites·5 claims
- 1165US12139763B2Methods for subtyping of lung adenocarcinomaGENECENTRIC THERAPEUTICS INC·Filed 2021·Granted Nov 12, 2024·0 cites·5 claims
- 1262US10196687B2Molecular diagnosis and typing of lung cancer variantsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2016·Granted Feb 5, 2019·0 cites·12 claims
- 1361US2015024399A1Molecular diagnosis and typing of lung cancer variantsUNIV NORTH CAROLINA·Filed 2014·Application pending·0 cites
- 1460US2019203296A1Methods for typing of lung cancerGENECENTRIC THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1558US2013338040A1LKB1 Levels and Brain Metastasis from Non-Small-Cell Lung Cancer (NSCLC)UNIV NORTH CAROLINA·Filed 2013·Application pending·0 cites
- 1657US2021074431A1Gene expression subtype analysis of head and neck squamous cell carcinoma for treatment managementGENECENTRIC THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1753US2025191689A1Methods for subtyping and treatment of head and neck squamous cell carcinomaGENECENTRIC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1850US2016201143A1LKB1 Levels and Brain Metastasis from Non-Small-Cell Lung Cancer (NSCLC)UNIV NORTH CAROLINA·Filed 2016·Application pending·0 cites
- 1944US12006554B2Methods for subtyping of head and neck squamous cell carcinomaGENECENTRIC THERAPEUTICS INC·Filed 2018·Granted Jun 11, 2024·0 cites·15 claims
- 2043US2015293098A1Methods for head and neck cancer prognosisUNIV NORTH CAROLINA·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Neil Hayes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →